Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

DEFINIUM THERAPEUTICS INC (DFTX)

8 + Investors. Track Smart Money conviction in DFTX. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%

8+

Inst. Holders

Hedge Fund Ownership: DFTX

How many hedge funds hold DFTX — quarterly history vs. share price
Quarterly hedge fund ownership of DFTX vs. share price

Market Analysis: DFTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DFTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

0 top-rated funds 0 high-conviction
Consensus
0.0
/ 10
breadth
×
Elite
0.1
/ 10
conviction
Hedge Fund Positioning: DFTX
2026 Q1 Stats Unlock in 11 days 8 + Investors

Track Smart Money conviction in DFTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 8 0 100%
13F Shares 11M 0 100%
Total Value $150M $0 100%
New Positions 8 0 +8
Increased Positions 0 0 -
Closed Positions 0 0 -
Reduced Positions 0 0 -
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: DFTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

8 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DFTX. Verified SEC 13F-HR filings.

Top 25 institutional holders of DFTX — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 PSP Research LLC 0.47% 34,800 $658K
2 AdvisorShares Investments LLC 0.31% 91,301 $1.7M
3 SEVEN GRAND MANAGERS, LLC 0.28% 225,000 $4.3M
4 Bay Rivers Group 0.21% 26,346 $498K
5 Candriam S.C.A. 0.13% 1,293,629 $24.4M
6 RPS ADVISORY SOLUTIONS LLC 0.12% 11,355 $215K
7 SHARPEPOINT LLC 0.11% 10,000 $189K
8 Twelve Points Wealth Management LLC 0.05% 12,245 $231K
9 CenterBook Partners LP 0.04% 42,829 $809K
10 China Universal Asset Management Co., Ltd. 0.03% 20,192 $382K
11 KINGSWOOD WEALTH ADVISORS, LLC 0.02% 26,591 $503K
12 King Wealth Management Group 0.02% 10,000
13 GSA CAPITAL PARTNERS LLP 0.02% 18,155
14 MONEY CONCEPTS CAPITAL CORP 0.01% 13,000 $246K
15 KESTRA PRIVATE WEALTH SERVICES, LLC 0.01% 50,588 $956K
16 PROFUND ADVISORS LLC 0.01% 14,196 $268K
17 North Star Investment Management Corp. 0.01% 7,571 $143K
18 Western Pacific Wealth Management, LP 0.01% 333 $6K
19 HOLLENCREST CAPITAL MANAGEMENT 0.01% 7,386 $140K
20 Chicago Partners Investment Group LLC 0.00% 9,307 $215K
21 Opal Wealth Advisors, LLC 0.00% 1,101 $21K
22 INTECH INVESTMENT MANAGEMENT LLC 0.00% 24,990 $472K
23 Police & Firemen's Retirement System of New Jersey 0.00% 27,361 $517K
24 Concurrent Investment Advisors, LLC 0.00% 21,285 $402K
25 DIVERSIFY WEALTH MANAGEMENT, LLC 0.00% 11,000 $225K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — DEFINIUM THERAPEUTICS INC (DFTX)

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.